As more life science companies prepare to launch new products and drive growth, senior-level finance and accounting professionals are shouldering greater responsibilities, with higher expectations from stakeholders. CBI’s Financial Strategies and Accounting for Bioscience Companies is tailored to the distinctive business needs and technical accounting challenges for small-middle market biotech, pharmaceutical and device companies.